Cancer Research UK logo.
SearchDonate
  • Search

A trial of custirsen with docetaxel for prostate cancer that has spread (SYNERGY)

Overview

Cancer types:

Prostate cancer

Status:

Results

Phase:

Phase 3

Details

This trial looked at a drug called custirsen with chemotherapy for prostate cancer.It was for men whose:

  • cancer had spread to other parts of the body (advanced cancer)

  • hormone therapy had stopped working

This trial was open for men to join between 2010 and 2012. The researchers published results in 2017.

Recruitment start: 10 December 2010

Recruitment end: 7 November 2012

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Johann De Bono

Supported by

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Oncogenex

Teva Pharmaceutical Industries Ltd

Last reviewed: 3 July 2019

CRUK internal database number: 7860

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.